Myostatin inhibition therapy for insulin-deficient type 1 diabetes

While Type 1 Diabetes Mellitus (T1DM) is characterized by hypoinsulinemia and hyperglycemia, persons with T1DM also develop insulin resistance. Recent studies have demonstrated that insulin resistance in T1DM is a primary mediator of the micro and macrovascular complications that invariably develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Samantha K., Rebalka, Irena A., D’Souza, Donna M., Deodhare, Namita, Desjardins, Eric M., Hawke, Thomas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007491/
https://www.ncbi.nlm.nih.gov/pubmed/27581061
http://dx.doi.org/10.1038/srep32495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007491/
https://www.ncbi.nlm.nih.gov/pubmed/27581061
http://dx.doi.org/10.1038/srep32495

Ejemplares similares